 Nicholas Willard
Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurofibroma, Plexiform | 1 | 2023 | 10 | 0.840 |
Why?
| | Neurofibromatosis 1 | 1 | 2023 | 53 | 0.810 |
Why?
| | Glioma | 4 | 2025 | 395 | 0.620 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 11 | 0.570 |
Why?
| | Immunoglobulin kappa-Chains | 1 | 2017 | 20 | 0.540 |
Why?
| | Electrophoresis | 1 | 2017 | 32 | 0.540 |
Why?
| | Brain Neoplasms | 4 | 2025 | 1239 | 0.440 |
Why?
| | Multiple Myeloma | 1 | 2017 | 252 | 0.430 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 676 | 0.400 |
Why?
| | Infratentorial Neoplasms | 2 | 2023 | 63 | 0.390 |
Why?
| | Immunoglobulin G | 1 | 2017 | 893 | 0.390 |
Why?
| | Ependymoma | 2 | 2023 | 165 | 0.350 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1430 | 0.320 |
Why?
| | Brain | 1 | 2018 | 2677 | 0.240 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2129 | 0.240 |
Why?
| | Submandibular Gland | 1 | 2025 | 20 | 0.230 |
Why?
| | Transcriptome | 4 | 2025 | 972 | 0.230 |
Why?
| | Interleukin-5 | 1 | 2025 | 44 | 0.230 |
Why?
| | Ganglioglioma | 1 | 2025 | 35 | 0.230 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 26 | 0.230 |
Why?
| | Mast-Cell Sarcoma | 1 | 2024 | 6 | 0.230 |
Why?
| | Lupus Nephritis | 1 | 2025 | 63 | 0.230 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 95 | 0.230 |
Why?
| | Mastocytosis, Systemic | 1 | 2024 | 8 | 0.230 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2024 | 67 | 0.220 |
Why?
| | Lymphoma, Large-Cell, Anaplastic | 1 | 2024 | 20 | 0.220 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2024 | 44 | 0.220 |
Why?
| | RNA, Small Nuclear | 1 | 2023 | 37 | 0.210 |
Why?
| | Oncogene Proteins, Fusion | 2 | 2024 | 215 | 0.210 |
Why?
| | Gene Rearrangement | 1 | 2024 | 150 | 0.210 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2025 | 224 | 0.200 |
Why?
| | Brain Stem Neoplasms | 1 | 2023 | 83 | 0.190 |
Why?
| | raf Kinases | 1 | 2021 | 13 | 0.190 |
Why?
| | Ligands | 1 | 2023 | 664 | 0.180 |
Why?
| | Precision Medicine | 1 | 2025 | 433 | 0.180 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 152 | 0.160 |
Why?
| | Medulloblastoma | 1 | 2022 | 193 | 0.160 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 320 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 804 | 0.160 |
Why?
| | Plasmablastic Lymphoma | 1 | 2019 | 7 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2024 | 712 | 0.160 |
Why?
| | Mutation | 3 | 2025 | 3959 | 0.160 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2018 | 20 | 0.140 |
Why?
| | Databases, Bibliographic | 1 | 2018 | 32 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2024 | 1276 | 0.140 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 123 | 0.140 |
Why?
| | Transplant Recipients | 1 | 2019 | 184 | 0.130 |
Why?
| | RNA | 1 | 2023 | 921 | 0.130 |
Why?
| | Lymphoma, B-Cell | 1 | 2018 | 106 | 0.130 |
Why?
| | Disease Progression | 1 | 2023 | 2760 | 0.120 |
Why?
| | Humans | 15 | 2025 | 137782 | 0.110 |
Why?
| | Adult | 3 | 2023 | 38023 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2019 | 856 | 0.090 |
Why?
| | Male | 8 | 2025 | 67906 | 0.080 |
Why?
| | Child | 3 | 2025 | 21989 | 0.080 |
Why?
| | Mice | 2 | 2023 | 17794 | 0.080 |
Why?
| | Female | 6 | 2025 | 73465 | 0.070 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 13 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3577 | 0.060 |
Why?
| | Adolescent | 4 | 2025 | 21574 | 0.060 |
Why?
| | Astrocytoma | 1 | 2025 | 128 | 0.050 |
Why?
| | Animals | 2 | 2023 | 36951 | 0.050 |
Why?
| | Fatal Outcome | 1 | 2024 | 303 | 0.050 |
Why?
| | Chromosomes | 1 | 2023 | 107 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 2023 | 39 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2023 | 156 | 0.050 |
Why?
| | Cytidine Deaminase | 1 | 2023 | 61 | 0.050 |
Why?
| | Brain Stem | 1 | 2023 | 94 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 209 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 596 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 195 | 0.040 |
Why?
| | Survival Analysis | 1 | 2023 | 1325 | 0.040 |
Why?
| | Middle Aged | 2 | 2019 | 33554 | 0.040 |
Why?
| | Autoimmunity | 1 | 2025 | 908 | 0.040 |
Why?
| | Aged | 1 | 2018 | 24001 | 0.040 |
Why?
| | Kidney | 1 | 2025 | 1475 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2022 | 1396 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2024 | 6084 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2024 | 7637 | 0.020 |
Why?
| | Infant | 1 | 2025 | 9482 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 10837 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11105 | 0.020 |
Why?
|
|
Willard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|